AP&T: Editors' declarations of interest

No value of non‐selective beta‐blockers after TIPS‐insertion
par: Anja Tiede, et autres
Publié: (2024)

Editorial: The future of managing drug induced liver injury
par: Amanda Nicoll
Publié: (2024)

Letter: Critical appraisal of biologic therapy in early ulcerative colitis management—Addressing study limitations and the role of psychological resilience—Authors' reply
par: Vibeke Strande, et autres
Publié: (2024)

Impact of non‐selective beta blockers on further decompensation and death in decompensated cirrhosis: Benefit and risk stratification by MELD score
par: Ting Wang, et autres
Publié: (2024)

Correction to ‘Stromal Vascular Fraction With Platelet‐Rich Plasma Injection During Surgery is Feasible and Safe in Treatment‐Refractory Perianal Fistulising Crohn's Disease: A Pilot Study’
Publié: (2024)

Racial and ethnic disparities in untreated patients with hepatitis C virus‐related hepatocellular carcinoma but not in those with sustained virologic response
par: Jung Eun Park, et autres
Publié: (2024)

Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis ‐ prevalence, clinical impact, economic implications and management strategies
par: Pegah Golabi, et autres
Publié: (2024)

Editorial: H. pylori Antimicrobial Susceptibility Testing—An Expanding Toolbox
par: Suvithan Rajadurai, et autres
Publié: (2024)

Letter: Should ulcerative colitis be monitored more or less invasively? Authors' reply
par: Matthias Lenfant, et autres
Publié: (2024)

Editorial: Redefining liver health—Personalised approach to assessment of serum ALT in clinical practice. Authors' reply
par: Eunice X. X. Tan, et autres
Publié: (2024)

Application of clinical decision support tools for predicting outcomes with vedolizumab therapy in patients with inflammatory bowel disease: A KASID multicentre study
par: Kyuwon Kim, et autres
Publié: (2024)

Editorial: Inflammation and Not Glucocorticoid Therapy is the Key Driver of Fracture Risk in IBD
par: Darcy Quinn Holt, et autres
Publié: (2024)

Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing
par: Tomohiro Fukuda, et autres
Publié: (2024)

Featured Cover
par: Tarek Hassanein, et autres
Publié: (2024)

Editorial: Emulsifiers and thickeners in our food—Do they alter gut permeability?
par: Joshua Reid, et autres
Publié: (2024)

Clinical Trial: Safety and Efficacy of a Novel Oesophageal Delivery System for Topical Corticosteroids Versus Placebo in the Treatment of Eosinophilic Oesophagitis
par: Alfredo J. Lucendo, et autres
Publié: (2024)

Other causes of neurocognitive impairment than covert hepatic encephalopathy ( CHE ) are very frequent, either alone or associated with CHE , in cirrhotic patients with cognitive complaints
par: Philippe Sultanik, et autres
Publié: (2024)

A Prospective Study on the Prevalence of MASLD in Patients With Type 2 Diabetes and Hyperferritinaemia
par: Maral Amangurbanova, et autres
Publié: (2024)

Editorial: Extending upadacitinib induction dosing in ulcerative colitis—A delicate balance of efficacy and safety. Author's reply
par: Remo Panaccione
Publié: (2024)

Editorial: Sounding the alarm—The rising global burden of adolescent and young adult alcohol‐related liver disease
par: Victoria T. Kronsten, et autres
Publié: (2024)

Letter: Risks of proton pump inhibitor treatment in cirrhotic patients
par: Jiamei Wang, et autres
Publié: (2024)

Issue Information
Publié: (2024)

CAMP‐B score predicts the risk of hepatocellular carcinoma in patients with chronic hepatitis B after HBsAg seroclearance
par: Hye Won Lee, et autres
Publié: (2024)

Maladaptive weight control and eating behaviours in female adolescents/young adults are associated with increased risk of irritable bowel syndrome in adulthood: Results from the Growing Up Today Study (GUTS)
par: Keming Yang, et autres
Publié: (2024)

Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound
par: Cathy Lu, et autres
Publié: (2024)

Hepatic Events During Immune Checkpoint Inhibitor Treatment Between Liver and Non‐Liver Malignancies in Hepatitis B Endemic Areas
par: Yi‐Ping Hung, et autres
Publié: (2024)

Clinical Trial: Treatment of Functional Dyspepsia According to Subtype Compared With Empirical Proton Pump Inhibitor
par: Kee Huat Chuah, et autres
Publié: (2024)

Factors Associated With Abdominal Pain in Patients With Active and Quiescent Ulcerative Colitis: A Multicohort Study
par: Tom van Gils, et autres
Publié: (2024)

Global epidemiology of alcohol‐associated liver disease in adolescents and young adults
par: Pojsakorn Danpanichkul, et autres
Publié: (2024)

Editorial: Novel insights into the prognostic relevance of high‐dose PPI treatment in patients with cirrhosis
par: Dominik Bettinger, et autres
Publié: (2024)

Impact of Nonalcoholic Fatty Liver Disease on the Survival of People Living With HIV
par: Juan Macias, et autres
Publié: (2024)

Letter: Optimising public health policies to combat alcohol‐associated liver disease in youth—Addressing key methodological and regional challenges
par: Rui Zhang, et autres
Publié: (2024)

Editorial: Can dietary gluten restriction improve hepatic steatosis?
par: Hariklia Kranidioti, et autres
Publié: (2024)

Review article: Prevention of inflammatory bowel disease—The path forward
par: Sérgio Bronze, et autres
Publié: (2024)

The deep abdominal ultrasound transducer (DAX) increases the success rate and diagnostic accuracy of shear wave elastography for liver fibrosis assessment in patients with obesity—A prospective biopsy‐controlled study
par: David J. M. Bauer, et autres
Publié: (2024)

Review article: Diagnosis and management of laryngopharyngeal reflux
par: Amanda J. Krause, et autres
Publié: (2024)